Compounds useful for the treatment of pain in accord with the following structural diagram, ##STR00001## wherein A, R.sup.1, b, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are any of a number of groups as defined in the specification, and pharmaceutical compositions and methods of treatment utilizing such compounds.
Claims What is claimed is: 1. A compound in accord with structural diagram I; ##STR00011## wherein: R.sup.1 at each occurrence is independently selected from (C.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl, (R.sup.2).sub.bphenyl, (R.sup.2).sub.bheteroaryl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is an independently integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is selected from --CH.sub.2-- or a single bond, wherein if A is a single bond, then (R.sup.1).sub.b is R.sup.1; R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.4)alkoxy(C.sub.1 C.sub.4)alkyl; R.sup.3 and R.sup.5 at each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NH.sub.2 or NHR.sup.2; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or --NR.sup.2.sub.2; and R.sup.8 is H. 2. A compound in accord with structural diagram I; ##STR00012## wherein: R.sup.1 at each occurrence is independently selected from (C.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, (C.sub.1 C.sub.6)alkoxy, amino or NR.sup.2; A is a single bond and (R.sup.1).sub.b is R.sup.1; (R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.4)alkoxy(C.sub.1 C.sub.4)alkyl; R.sup.3 and R.sup.5 at each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl or (C.sub.1 C.sub.3)alkoxy; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.6)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or--NR.sup.2.sub.2; and R.sup.8 is H. 3. A method for the treatment of pain in a subject suffering therefrom, comprising: administering to said subject a pain-ameliorating effective amount of a compound according to claim 1. 4. A pharmaceutical composition comprising a therapeutically-effective amount of a compound according to claim 1 together with at least one pharmaceutically-acceptable excipient or diluent. 5. A method for preparing a compound according to claim 1, said method comprising: a) reacting a substituted 2,4-quinolinediol (structural diagram II) with three equivalents of an alkyl amine in N-methylpyrrolidinone and 6 N HCL in 2-propanol, in a sealed tube at a temperature of about 180.degree. C.; ##STR00013## wherein R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined as in claim 1; b) chlorinating the 2-hydroxy-4-aminoquinoline compound according to structural diagram III by refluxing with POCl.sub.3 to form a compound in accord to structural diagram IV; ##STR00014## wherein R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined as in claim 1; and c) reacting 2-chloro-4-aminoquinoline precursors with aromatic amine a in N-methylpyrrolidinone at temperatures of 100 180.degree. C., ##STR00015## wherein A, b, R.sup.1, R.sup.4, R.sup.5, R.sup.6, R.sup.7, and R.sup.8 are as defined as in claim 1. 6. A method for preparing a compound in accord with structural diagram I: ##STR00016## wherein: R.sup.1 at each occurrence is independently selected from (.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl, (R.sup.2).sub.bheteroaryl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is selected from --CH.sub.2-- or a single bond, wherein if A is a single bond, then (R.sup.1).sub.b is R.sup.1; R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.4)alkoxy(C.sub.1 C.sub.4)alkyl; R.sup.3 and R.sup.5 at each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NH.sub.2 or NHR.sup.2; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or --NR.sup.2.sub.2; and R.sup.8 is selected from H or methyl; said method comprising: a) reacting a substituted 2,4-quinolinediol (structural diagram II) with three equivalents of an alkyl amine in N-methylpyrrolidinone and 6 N HCL in 2-propanol, in a sealed tube at a temperature of about 180.degree. C.; ##STR00017## wherein R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined as above; b) chlorinating the 2-hydroxy-4-aminoquinoline compound according to structural diagram III by refluxing with POCl.sub.3 to form a compound according to structural diagram IV; ##STR00018## wherein R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined as above; and c) reacting 2-chloro-4-aminoquinoline precursors with aromatic amines in N-methylpyrrolidinone at temperatures of 100 180.degree. C. in a parallel fashion using a robotic instrumentality ##STR00019## wherein A, b, R.sup.1, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are as defined as above. 7. A compound in accord with structural diagram I; ##STR00020## wherein: R.sup.1 at each occurrence is independently selected from an alkyl having 2, 3, 4, 5, 6, 7 or 8 carbon atoms, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl, (R.sup.2).sub.bheteroaryl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, amino, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is selected from --CH.sub.2-- or a single bond, wherein if A is a single bond, ten (R.sup.1).sub.b is R.sup.1; R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.6)alkoxy(C.sub.1 C.sub.4)alkyl; R.sup.3 and R.sup.5 at each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NHR.sup.2; or NHR.sup.2; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or --NR.sup.2.sub.2, and R.sup.8 is selected from H or methyl. 8. A compound in accord with structural diagram I; ##STR00021## wherein: R.sup.1 at each occurrence is independently selected from (C.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl (R.sup.2).sub.bheteroaryl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, amino, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is selected from --CH.sub.2-- or a single bond, wherein if A is a single bond, then (R.sup.1).sub.b is R.sup.1; R.sup.4 is selected from an alkyl having 2, 3, 4, 5, or 6 carbon atoms or (C.sub.1 C.sub.6)alkoxy(C.sub.1 C.sub.4)alkyl; R.sup.3 and R.sup.5 at each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NH.sub.2 or NHR.sup.2; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or --NR.sup.2.sub.2; and R.sup.8is selected from H or methyl. 9. A compound in accord with structural diagram I; ##STR00022## wherein: R.sup.1 at each occurrence is independently selected from (C.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl, (R.sup.2).sub.bheteroaryl or (R.sup.3).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6alkyl, heterocyclyl, OH, amino, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is selected from --CH.sub.2-- or a single bond, wherein if A is a single bond, then (R.sup.1).sub.b is R.sup.1; R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.4))alkoxy(C.sub.1 C.sub.4)alkyl; R.sup.3 is selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.5 is selected from H or an alkyl having 2, 3, 4, 5, or 6 carbon atoms; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NH.sub.2 or NHR.sup.2; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or --NR.sup.2.sub.2; and R.sup.8 is selected from H or methyl. 10. A compound in accord with structural diagram I; ##STR00023## wherein: R.sup.1 at each occurrence is independently selected from (C.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl, (R.sup.2).sub.bheteroaryl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.1 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, amino, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is selected from --CH.sub.2-- or a single bond, wherein if A is a single bond, then (R.sup.1).sub.b is R.sup.1; R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.4)alkoxy(C.sub.1 C.sub.6)alkyl; R.sup.3 and R.sup.5 at each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 selected from halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NH.sub.2 or NHR.sup.2; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or --NR.sup.2.sub.2; and R.sup.8 is selected from H or methyl. 11. A compound in accord with structural diagram I; ##STR00024## wherein: R.sup.1 at each occurrence is independently selected from (C.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl, (R.sup.2).sub.bheteroaryl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, amino, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is selected from --CH.sub.2-- or a single bond, wherein if A is a single bond, then (R.sup.1).sub.b is R.sup.1; R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.4)alkoxy(C.sub.1 C.sub.4)alkyl; R.sup.3 and R.sup.5 at each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NH.sub.2 or NHR.sup.2; R.sup.7 is selected from halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or --NR.sup.2.sub.2; and R.sup.8 is selected from H or methyl. 12. A compound in accord with structural diagram I; ##STR00025## wherein: R.sup.1 at each occurrence is independently selected from (C.sub.1 C.sub.8)alkyl, (C.sub.2 C.sub.8)alkenyl (R.sup.2).sub.bphenyl, (R.sup.2).sub.bheteroaryl or (R.sup.2).sub.bbicyclic heteroaryl; b at each occurrence is independently an integer selected from 0, 1, 2 and 3; R.sup.2 at each occurrence is independently selected from halogen, (C.sub.1 C.sub.6)alkyl, heterocyclyl, OH, amino, (C.sub.1 C.sub.6)alkoxy or NR.sup.3.sub.2; A is --CH.sub.2; R.sup.4 is selected from (C.sub.1 C.sub.6)alkyl or (C.sub.1 C.sub.4)alkoxy(C.sub.1 C.sub.6)alkyl; R.sup.3 and R.sup.5 each occurrence are independently selected from H or (C.sub.1 C.sub.4)alkyl; R.sup.6 is selected from H, halogen, (C.sub.1 C.sub.3)alkyl, (C.sub.1 C.sub.3)perfluoroalkyl, (C.sub.1 C.sub.3)alkoxy, hydroxy, NH.sub.2 or NHR.sup.2; R.sup.7 is selected from H, halogen, (C.sub.1 C.sub.6)alkyl, (C.sub.1 C.sub.4)perfluoroalkyl, (C.sub.1 C.sub.6)alkoxy, hydroxy, (C.sub.1 C.sub.6)alkanoyl, C(.dbd.O)NR.sup.2.sub.2 or NR.sup.2.sub.2; and R.sup.8 is selected from H or methyl. 